Stereotactic ablative radiotherapy (SABR), historically known as stereotactic body radiation therapy (SBRT), has rapidly developed into an important tool radiation oncologists use in the treatment of lung cancers. The indications for treatment of medically inoperable lung cancers have become well ...
Stereotactic Body Radiation Therapy (SBRT)Explore This Section Stereotactic body radiation therapy (SBRT), also known as stereotactic ablative radiotherapy, is an advanced type of radiation therapy. SBRT delivers very high doses of radiation to precisely target the tumor by using several beams of ...
Stereotactic ablative body radiotherapy (SABR) represents a technological breakthrough in radiotherapy technique, with proven benefits to patients in terms of improved tumour control and overall survival. The key components of SABR are described. The current evidence base for SABR for the treatment of ...
Image-guided stereotactic ablative radiotherapy (SABR; also called stereotactic body radiotherapy or radiosurgery) has become a standard treatment for medically inoperable peripherally located stage I non–small-cell lung cancer (NSCLC) and can achieve local control rates in excess of 90%. However, ...
The use of stereotactic ablative body radiotherapy (SABR) in patients with early-stage non–small cell lung cancer (NSCLC) has been shown to be safe and effective.1, 2 In the present era, SABR is commonly discussed as an alternative to surgery based on the results of various evaluations.2...
Preoperative stereotactic ablative body radiotherapy with postoperative conventional irradiation of soft tissue sarcomas: protocol overview with a prelimin... Preoperative radiotherapy in patients with soft tissue sarcomas is characterized by important advantages: high precision of dose delivery, reduction of ...
摘要: Some patients with early stage large cell neuroendocrine carcinoma (LCNEC) of the lung are not surgical candidates and will be managed with radiotherapy. We used the national cancer database to identify predictors of stereotactic radiotherapy and compare outcomes.关键词:...
0笔记 摘要原文 To update the 2012 UK stereotacticablative radiotherapy (SABR) Consortium survey and assess the development of SABR services across the UK over the past 6 years. Use the results to share practice and continue to drive forward technique development, aid standardization and by highlight...
Background: Stereotactic body radiotherapy (SBRT) or stereotactic ablative radiotherapy (SABR) has been reported to be a comparable alternative therapy to surgery for patients with T1-3N0M0 non-small cell lung cancer (NSCLC). However, it has not been clarified whether SBRT/SABR is as effective ...
Avelumab combined with stereotactic ablative body radiotherapy in metastatic castration-resistant prostate cancer: the phase 2 ICE-PAC clinical trial. Eur Urol. 2022;81:253–62. Article CAS PubMed Google Scholar Fakhrejahani F, Madan RA, Dahut WL, Karzai F, Cordes LM, Schlom J, et al. ...